Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7QIV

Structure of human C3b in complex with the EWE nanobody

7QIV の概要
エントリーDOI10.2210/pdb7qiv/pdb
関連するPDBエントリー6EHG 6RU5
分子名称Complement C3 beta chain, Complement C3b alpha' chain, Nanobody EWE, ... (4 entities in total)
機能のキーワードcomplement, alternative pathway, antibody, nanobody, protein engineering, immune system
由来する生物種Lama glama
詳細
タンパク質・核酸の鎖数3
化学式量合計190700.22
構造登録者
Pedersen, H.,Andersen, G.R. (登録日: 2021-12-16, 公開日: 2022-02-16, 最終更新日: 2024-10-16)
主引用文献Pedersen, H.,Jensen, R.K.,Hansen, A.G.,Petersen, S.V.,Thiel, S.,Laursen, N.S.,Andersen, G.R.
Structure-Guided Engineering of a Complement Component C3-Binding Nanobody Improves Specificity and Adds Cofactor Activity.
Front Immunol, 13:872536-872536, 2022
Cited by
PubMed Abstract: The complement system is a part of the innate immune system, where it labels intruding pathogens as well as dying host cells for clearance. If complement regulation is compromised, the system may contribute to pathogenesis. The proteolytic fragment C3b of complement component C3, is the pivot point of the complement system and provides a scaffold for the assembly of the alternative pathway C3 convertase that greatly amplifies the initial complement activation. This makes C3b an attractive therapeutic target. We previously described a nanobody, hC3Nb1 binding to C3 and its degradation products. Here we show, that extending the N-terminus of hC3Nb1 by a Glu-Trp-Glu motif renders the resulting EWE-hC3Nb1 (EWE) nanobody specific for C3 degradation products. By fusing EWE to N-terminal CCP domains from complement Factor H (FH), we generated the fusion proteins EWEnH and EWEµH. In contrast to EWE, these fusion proteins supported Factor I (FI)-mediated cleavage of human and rat C3b. The EWE, EWEµH, and EWEnH proteins bound C3b and iC3b with low nanomolar dissociation constants and exerted strong inhibition of alternative pathway-mediated deposition of complement. Interestingly, EWEnH remained soluble above 20 mg/mL. Combined with the observed reactivity with both human and rat C3b as well as the ability to support FI-mediated cleavage of C3b, this features EWEnH as a promising candidate for studies in rodent models of complement driven pathogenesis.
PubMed: 35935935
DOI: 10.3389/fimmu.2022.872536
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.8 Å)
構造検証レポート
Validation report summary of 7qiv
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon